Education
About Us
Working with TipRanks
Follow Us
Chemomab Therapeutics (CMMB)
NASDAQ:CMMB
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -53.25K | $ -66.83K | $ -57.77K | $ -34.02K | $ -80.00K |
| Operating Income | $ -14.74M | $ -25.46M | $ -28.53M | $ -12.37M | $ -5.97M |
| EBITDA | $ -13.96M | $ -25.39M | $ -28.48M | $ -12.33M | $ -5.95M |
| Net Income | $ -13.95M | $ -24.22M | $ -27.65M | $ -12.48M | $ -5.95M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 14.27M | $ 19.78M | $ 39.89M | $ 61.16M | $ 11.70M |
| Total Assets | $ 16.96M | $ 22.15M | $ 43.06M | $ 64.35M | $ 12.48M |
| Total Debt | $ 324.00K | $ 392.00K | $ 214.00K | $ 343.00K | $ 607.00K |
| Net Debt | $ -5.75M | $ -8.90M | $ -13.30M | $ -14.34M | $ -11.07M |
| Total Liabilities | $ 3.43M | $ 5.15M | $ 6.84M | $ 2.89M | $ 1.67M |
| Stockholders' Equity | $ 13.54M | $ 17.00M | $ 36.22M | $ 61.47M | $ 10.80M |
| Cash Flow | |||||
| Free Cash Flow | $ -15.46M | $ -23.55M | $ -20.36M | $ -12.62M | $ -12.84M |
| Operating Cash Flow | $ -15.46M | $ -23.55M | $ -20.29M | $ -12.38M | $ -12.80M |
| Investing Cash Flow | $ 2.31M | $ 15.84M | $ 19.46M | $ -45.22M | $ 102.72K |
| Financing Cash Flow | $ 9.91M | $ 3.49M | $ -804.84K | $ 61.12M | $ 299.08K |